<DOC>
	<DOCNO>NCT01172275</DOCNO>
	<brief_summary>Pediatric Obsessive-Compulsive Disorder ( OCD ) affect 1-3 % child . The investigator currently effective first-line intervention pediatric OCD Cognitive Behavioral Therapy ( CBT ) pharmacotherapy serotonin reuptake inhibitor ( SRIs ) . However , roughly half child OCD still clinically significant OCD symptom despite treatment first-line pharmacological treatment CBT intervention OCD . Furthermore , pharmacological treatment OCD child increase side effect burden compare adult . Novel treatment child OCD need . N-acetylcysteine ( NAC ) natural supplement act antioxidant glutamate modulating agent . NAC use safely decades dos 20-40 time higher trial antidote acetaminophen overdose . The side-effect commonly see NAC nausea side-effect seldom see dos use trial . NAC recently demonstrate effective double-blind , placebo-controlled trial adult trichotillomania ( chronic hair pull ) . Trichotillomania obsessive-compulsive spectrum disorder hypothesize closely related OCD . In trial NAC evidence efficacy treat diverse psychiatric condition bipolar depression , schizophrenia cocaine dependence . The investigator conduct trial determine NAC effective treating OCD .</brief_summary>
	<brief_title>N-acetylcysteine ( NAC ) Pediatric Obsessive-Compulsive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Children age 817 year . Primary diagnosis OCD . Duration OCD great 6 month . Significant Current OCD symptom : Current CYBOCS score &gt; = 16 . Comorbid bipolar disorder , psychotic disorder , substance use disorder , developmental disorder mental retardation ( IQ &lt; 70 ) . Recent change ( less 4 week ) medication potential effect OCD severity ( Selective Serotonin Reuptake Inhibitors , clomipramine , naltrexone , lithium , psychostimulants , anxiolytic , antipsychotic ) . Medication change define include either dose change medication discontinuation . Recent change behavioral treatment OCD comorbid condition within last 4 week initiation behavioral therapy tic within last 12 week . Asthma require medication use within last 3 month ( case report link intravenous NAC administration asthma exacerbation ) Known hypersensitivity previous anaphylactoid reaction acetylcysteine component preparation . Positive pregnancy test drug screen test . Previous use Nacetylcysteine ( dose great 600mg 2 week ) . Previous history suspicion cystinuria possibility form kidney stone .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Obsessive-Compulsive Disorder</keyword>
	<keyword>OCD</keyword>
</DOC>